BMC GASTROENTEROL 润色咨询

BMC GASTROENTEROLOGY

出版年份:2001 年文章数:3696 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:1.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2023-11-15 10e45bd6m59暂无昵称 来自美国

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:结直肠肿瘤
    经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2024-04-04 ms9000000143854069 来自新疆

    The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2024-03-12 12187ebfm02暂无昵称 来自贵州省

    审稿很慢3个多月 大修1次后接收 感谢

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2023-08-10 152608_3287 来自江西省

    投稿命中率:50.0
    偏重的研究方向:胃肠道
    经验分享:还在送审中,希望发表

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2024-03-06 ms5000000189258852 来自广东省

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:脂肪肝
    经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2023-11-23 152608_3287 来自江西省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:胃肠道
    经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2023-08-26 ms5000000089678974 来自江苏省

    BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2023-06-20 ms2000000713462597 来自江西省

    审稿速度:12.0 | 投稿命中率:25.0
    偏重的研究方向:单基因泛癌分析;生信
    经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿
    拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;
    拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝
    拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2023-04-25 1481eb82m89暂无昵称 来自北京

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:编辑的审稿意见比较友好

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2168627, encodeId=7014216862ed1, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:结直肠肿瘤<br>经验分享:时间比较长,但感觉审稿人比较友好,不着急的话,可以试试,稿费2800刀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34415404840, createdName=10e45bd6m59暂无昵称, createdTime=Wed Nov 15 10:38:21 CST 2023, time=2023-11-15, status=1, ipAttribution=美国), GetPortalCommentsPageByObjectIdResponse(id=2196955, encodeId=04ce2196955ee, content=The editors' decision can take several weeks as they may consult peer reviewers.是啥意思,是外审了嘛 还是在编辑呢里。 详情呢里显示peer review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75385537348, createdName=ms9000000143854069, createdTime=Thu Apr 04 21:34:20 CST 2024, time=2024-04-04, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192829, encodeId=7be3219282938, content=审稿很慢3个多月 大修1次后接收 感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dda2262196, createdName=12187ebfm02暂无昵称, createdTime=Tue Mar 12 18:21:16 CST 2024, time=2024-03-12, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2152072, encodeId=34b421520e290, content=投稿命中率:50.0<br>偏重的研究方向:胃肠道<br>经验分享:还在送审中,希望发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Aug 10 09:43:53 CST 2023, time=2023-08-10, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191384, encodeId=903b21913842e, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:脂肪肝<br>经验分享:一周返修意见回来,返修时间两周,回复后,等一个月就直接录用,总共两个月投稿到录用。特别快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=735e9020587, createdName=ms5000000189258852, createdTime=Wed Mar 06 11:20:27 CST 2024, time=2024-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170406, encodeId=622321e040602, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:胃肠道<br>经验分享:太恶心的杂志了,大修之后还找了不一样的审稿人,而且等待的时间非常漫长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25a66205238, createdName=152608_3287, createdTime=Thu Nov 23 08:21:58 CST 2023, time=2023-11-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了 拒稿的可能性大吗?要不要再催一下呢?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143875, encodeId=bb4a21438e586, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:单基因泛癌分析;生信<br>经验分享:非常非常慢,途中催稿过2次,半年多后直接给出拒稿<br>拒稿理由1:研究老套、研究不够深、专业生信人员分析很快得出类似研究,直接拒绝;<br>拒稿理由2:要求上传低版本的word,要不然阅读出现重叠错误;前言没有肿瘤的流行背景,研究常见,拒绝<br>拒稿理由3:理由点很多,比较细节,有一定的实际帮助作用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:33:04 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2128306, encodeId=a97f212830650, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:编辑的审稿意见比较友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0145270039, createdName=1481eb82m89暂无昵称, createdTime=Tue Apr 25 21:19:25 CST 2023, time=2023-04-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127343, encodeId=059e212e343e5, content=审稿速度:12.0<br>偏重的研究方向:预后;肝癌<br>经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3875535363, createdName=zzyt981, createdTime=Thu Apr 20 21:33:53 CST 2023, time=2023-04-20, status=1, ipAttribution=北京)]
    2023-04-20 zzyt981 来自北京

    审稿速度:12.0
    偏重的研究方向:预后;肝癌
    经验分享:2022年6月投稿,2023年4月20日接收,经历了一次修改

    0

共154条页码: 1/16页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分